Breast cancer in women who undergo screening mammography: Relationship of hormone replacement therapy to stage and detection method

Radiology

Volumn 208, Issue 3, 1998, Pages 725-728

  Roubidoux, Marilyn A ^a   Wilson, Todd E ^a   Orange, Richard J ^d   Fitzgerald, J Thomas ^b   Helvie, Mark A ^a   Packer, Sasha A ^c  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b Department of Medical Education   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Breast radiography; Cancer screening; Hormones

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031752118     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.208.3.9722852     Document Type: Article

References (20)

1. Speroff L. Menopause and hormone replacement therapy. Clin Geriatr Med 1993; 9:33-55.
2. Laya MB, Larson EB, Taplin SH, White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88:643-649.
3. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-1593.
4. Thurfjell EL, Lindgren JAA. Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala County. Radiology 1994; 193:351-357.
5. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1996; 151:75-78.
6. Psaty BM, Heckbert SR, Atkins D, et al. A review of the association of estrogens and progestrins with cardiovascular disease in postmenopausal women. Arch Intern Med 1993; 153:1421-1427.
7. Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327:620-627.
8. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336:1769-1775.
9. Khoo KS, Chick P. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy. Med J Aust 1992; 156:124-132.
10. Thurfjell EL, Holmberg LH, Persson IR. Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 1997; 203: 339-341.
11. Strickland DM, Gambrell RD Jr, Butzin CA, Strickland K. The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynecol 1992; 80:400-404.
12. Bergkvist L, Persson I, Bergstrom R, Krusemo UB. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 1989; 130:221-228.
13. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336:1769-1775.
14. Jones C, Ingram D, Mattes E, Hahnel R. The effect of hormone replacement therapy on prognostic indices in women with breast cancer. Med J Aust 1994; 161:106-110.
15. Brinton LA, Schairer C. Postmenopausal hormone-replacement therapy: time for a reappraisal? N Engl J Med 1997; 336:1821-1822.
16. Cyrlak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. AJR 1993; 161:1177-1183.
17. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196:433-437.
18. Sickles EA. Quality assurance: how to audit your own mammography practice. Radiol Clin North Am 1992; 30:265-275.
19. Schapira DV, Levine RB. Breast cancer screening and compliance and evaluation of lesions. Cancer 1996; 80:15-25.
20. Fox SA, Siu AL, Stein JA. The importance of physician communication on breast cancer screening of older women. Arch Intern Med 1994; 154:2058-2068.